Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Mulita Sanyanusin, Suparat Tudsamran, Rattapoom Thaiwong, Supannikar Tawinwung, Nobuhiro Nishio, Yoshiyuki Takahashi, Nattiya Hirankarn, Koramit Suppipat
Publikováno v:
Cytotherapy. 25:397-406
Chimeric antigen receptor (CAR) T cell is a novel therapy for relapse and refractory hematologic malignancy. Characteristics of CAR T cells are associated with clinical efficacy and toxicity. The type of serum supplements used during cultivation affe
Autor:
Franco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, Virginie Gandemer, Fanny Rialland, Maura Faraci, Yoshiyuki Takahashi, Katsuyoshi Koh, Henrique Bittencourt, Grace Cleary, Christine Rosko, Pantelia Roussou, Annie St. Pierre, Anirudh Prahallad, Cristina Díaz-de-Heredia
Publikováno v:
Blood. 140:1376-1378
Autor:
Hiroyuki Shimada, Akihiko Tanizawa, Takeshi Kondo, Tokiko Nagamura-Inoue, Masahiro Yasui, Arinobu Tojo, Hideki Muramatsu, Tetsuya Eto, Noriko Doki, Masatsugu Tanaka, Maho Sato, Maiko Noguchi, Naoyuki Uchida, Yoshiyuki Takahashi, Naoki Sakata, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Kazuteru Ohashi
Publikováno v:
Transplantation and Cellular Therapy. 28:376-389
The breakthrough effects of tyrosine kinase inhibitors (TKIs) have lessened indications for allogeneic hematopoietic stem cell transplantation (HSCT) in chronic myeloid leukemia (CML). However, HSCT is still attractive for children and adolescents/yo
Autor:
Ryo Maemura, Manabu Wakamatsu, Kana Matsumoto, Hirotoshi Sakaguchi, Nao Yoshida, Asahito Hama, Taro Yoshida, Shunsuke Miwata, Hironobu Kitazawa, Kotaro Narita, Shinsuke Kataoka, Daisuke Ichikawa, Motoharu Hamada, Rieko Taniguchi, Kyogo Suzuki, Nozomu Kawashima, Eri Nishikawa, Atsushi Narita, Yusuke Okuno, Nobuhiro Nishio, Koji Kato, Seiji Kojima, Kunihiko Morita, Hideki Muramatsu, Yoshiyuki Takahashi
Publikováno v:
Cell transplantation. 31
Melphalan is widely used for hematopoietic stem cell transplantation (HSCT) conditioning. However, the relationship between its pharmacokinetic (PK) and transplantation outcomes in children has not been thoroughly investigated. We prospectively analy
Autor:
Yuichi Ishikawa, Tatsunori Goto, Katsuyoshi Kato, Tetsuya Nishida, Yoshiyuki Takahashi, Sonoko Kamoshita, Seitaro Terakura, Akihiro Hirakawa, Hitoshi Kiyoi, Nobuhiro Nishio, Satoshi Nishiwaki, Yoko Ushijima, Makoto Murata, Yoshiya Adachi, Tadashi Matsushita, Yoshihisa Kodera, Satoshi Suzuki
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 542-553 (2021)
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 542-553 (2021)
Mesenchymal stem cells (MSCs) have immunomodulatory properties and support hematopoiesis in the bone marrow (BM). To develop a new strategy to not only prevent graft‐vs‐host disease (GVHD) but also to enhance engraftment, a phase I trial of cord
Autor:
Toshihiko Suzuki, Atsuto Onoda, Hidenori Yamamoto, Masahiro Hayakawa, Yuma Kitase, Takayuki Nakayama, Yoshiyuki Takahashi, Yuichiro Sugiyama, Shigeki Saito, Taichi Kato, Yoshiaki Sato, Kazuto Ueda, Haruka Mimatsu
Publikováno v:
Cytotherapy. 22:180-192
Perinatal bronchopulmonary dysplasia (BPD) is defined as lung injury in preterm infants caused by various factors, resulting in serious respiratory dysfunction and high mortality. The administration of mesenchymal stem/stromal cells (MSCs) to treat/p
Autor:
Yuichiro Sugiyama, Toshihiko Suzuki, Alkisti Mikrogeorgiou, Akihito Yamamoto, Hiroshi Yukawa, Masahiro Tsuji, Kohki Matsubara, Hitoshi Hirata, Shinobu Shimizu, Kazuto Ueda, Yoshinobu Baba, Masahiro Hayakawa, Yuka Tsukagoshi Okabe, Yuma Kitase, Yoshiyuki Takahashi, Yoshiaki Sato
Publikováno v:
Stem Cells and Development. 29:63-74
Recently, cell therapy has been developed as a novel treatment for perinatal hypoxic-ischemic encephalopathy (HIE), which is an important cause of neurological disorder and death, and stem cells from human exfoliated deciduous teeth (SHED) express ea
Autor:
Hideki Muramatsu, Seiji Kojima, Daisuke Ichikawa, Taichi Kato, Keiko Ohta-Ogo, Motoharu Hamada, Hatsue Ishibashi-Ueda, Yusuke Okuno, Yoshie Fukasawa, Nozomu Kawashima, Eri Nishikawa, Nobuhiro Nishio, Yoshiyuki Takahashi, Atsushi Narita
Publikováno v:
Transplantation and cellular therapy. 27(9)
Pulmonary hypertension (PH) is associated with high morbidity in children undergoing hematopoietic stem cell transplantation (HSCT). However, owing to the lack of sequential echocardiography, the nature of the condition is not fully understood. This
Autor:
Norio Shimizu, Yoshinori Ito, Masahiro Yoshida, Satoko Morishima, Masao Seto, Atsushi Kikuta, Keiji Iwatsuki, Yusuke Okuno, Kenichi Yoshida, Jun-ichi Kawada, Yasushi Isobe, Kenichi Chiba, Hiroko Tanaka, Koichi Ohshima, Seiji Kojima, Shigeyoshi Fujiwara, Masaaki Noguchi, Hideki Muramatsu, Keisei Kawa, Hiroshi Kimura, Takayuki Murata, Seishi Ogawa, Norihiro Murakami, Akihisa Sawada, Masami Inoue, Yoshitaka Sato, Seiichi Kato, Tetsuya Nishida, Satoru Miyano, Shigeo Nakamura, Fumi Goshima, Yoshiyuki Takahashi, Tatsuya Okuno, Tetsushi Yoshikawa, Yohei Narita, Hitoshi Kiyoi, Yuichi Shiraishi, Takahiro Watanabe
Publikováno v:
Nature Microbiology. 4:404-413
Epstein-Barr virus (EBV) infection is highly prevalent in humans and is implicated in various diseases, including cancer1,2. Chronic active EBV infection (CAEBV) is an intractable disease classified as a lymphoproliferative disorder in the 2016 World
Autor:
Yoshiyuki Takahashi, Nobuhiro Nishio, Hideki Muramatsu, Rieko Taniguchi, Yuichi Ishikawa, Makoto Murata, Nozomu Kawashima, Eri Nishikawa, Ryo Hanajiri, Motoharu Hamada, Atsushi Narita
Publikováno v:
Blood. 138:3831-3831
Introduction: Chimeric antigen receptor-modified T cells targeting CD19 (CD19.CAR-T cells) have shown clinical success in patients with hematological malignancies. Despite the encouraging results obtained with this novel therapy, a major concern to i